Table 2 shows a comparison of prevalences of presence of TPO autoantibodies with hypothyroidism (presumably Hashimoto thyroiditis) and presence of autoantibodies (TPO and/or Tg) without hypothyroidism (most likely with polyclonal activation of B cell) among rheumatic disease patients, in relation to controls. This evidence concerns the gene TPO and Hashimoto thyroiditis.